Back to School: How biopharma can reboot drug development. Access exclusive analysis here

EPS watch

EPS watch

Company 3Q07 EPS est 3Q07 EPS actual Outcome Growth from 3Q06 11/9 cls Wk chg % chg Mcap chg 11/9 Mcap
Albany Molecular (AMRI) $0.09 $0.06 Missed by $0.03 50% $11.98 -$5.00 -29% -$164.8 $394.9
The contract R&D services provider reported 3Q07 revenues of $47.6M, up 8% from $44.2M in 3Q06.

Read the full 532 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers